Ken Burns' new production, 'Cancer: The Emperor of All Maladies,' explores the history, future and impact of the disease. It is scheduled to air on PBS stations March 30, 31 and April 1 (check local listings). Next Avenue gathered clips from the show, including moving personal narratives of facing t…
Meet Children's Hospital of Philadelphia's team of highly regarded medical experts including surgeons, as well as many dedicated nurses, specialists, patient advocates and others who defy skeptics to perform groundbreaking medicine. TWICE BORN – STORIES FROM THE SPECIAL DELIVERY UNIT premieres tomorrow at 8/7c on PBS.
CANCER: THE EMPEROR OF ALL MALADIES premieres March 30th – April 1st on PBS. In this video, Katie Couric, Yahoo Global News Anchor and co-founder of Stand Up To Cancer, talks about why it’s so important for everyone to watch this film. #CancerFilm
Shelly and Bobby travel from Massachusetts after learning their baby has spina bifida, a debilitating condition that causes a range of problems including impaired mobility, hydrocephalus and a number of other lifelong challenges. See how their journey at the Children's Hospital of Philadelphia begins during the premiere of TWICE BORN – STORIES FROM THE SPECIAL DELIVERY UNIT on Tuesday, March 31 at 8/7c on PBS.
Niall is striving to bring watchmaking back to the United States with its luxury timepiece, the Niall One. On this #ShowMeKC from KCPT, Niall founder Mike Wilson talks about the company and watchmaking.
Niall Luxury is striving to bring watch manufacturing back to the United States, offering an ever-evolving luxury timepiece in the Niall One. Parts are manufactured all over the states, and assembled in the KC crossroads by hand.
A growing national movement to normalize end-of-life discussions among family and friends has gained traction in recent months. As Medicare considers whether to cover such conversations with physicians, The Conversation Project, a Boston-based non-profit, is highlighting the importance of talking op…
March 28, 2015 at 11:00 pm
This feed is experiencing technical difficulties. Connect with us on Twitter: @pbs